DGX up +1.69% percent right now. $DGX High is at 62.77 and the Low 61.62 with current volume of 522,397.
Recent News posted below.
DGX Quest Diagnostics Inc Recent Headline News
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Quest Diagnostics Is Down 1.9% (DGX)
Comtex SmarTrend(R) - 2 hrs 15 mins ago
When Quest Diagnostics (NYSE
GX) reported earnings 18 days ago on October 23rd, 2014, analysts, on average, expected the company to report earnings of $1.07 on sales of $1.9 billion. The company actually reported EPS of $1.10 on sales of $1.9 billion, beating EPS estimates by $0.03 and beating revenue estimates by $32.2 million. Since the company's report, shares of Quest Diagnostics have fallen from $62.88 to $61.69, representing a loss of 1.9% in the past 18 days.
DGX: 62.81 (+1.12)
Technical Updates, Quarterly Earnings, Legislated Requirements, Lawsuit Dismissal, and Revised Operational Structure - Research Reports on United Rentals, Lilly, Quest Diagnostics, Agilent and GE
PR Newswire - Thu Nov 06, 7:40AM CST
Today, Analysts Review released its research reports regarding United Rentals, Inc. (NYSE: URI), Eli Lilly and Company (NYSE: LLY), Quest Diagnostics Inc. (NYSE: DGX), Agilent Technologies Inc. (NYSE: A) and General Electric Company (NYSE: GE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7739-100free.
GE: 26.44 (+0.03), A: 41.32 (+0.39), DGX: 62.81 (+1.12), LLY: 68.35 (+1.75), URI: 113.66 (+0.27)
Quest Diagnostics (DGX): Stock With Unusual Social Activity
at The Street - Wed Nov 05, 9:35AM CST
Trade-Ideas LLC identified Quest Diagnostics (DGX) as an unusual social activity candidate
DGX: 62.81 (+1.12)
Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents Outlook at Investor Day
PR Newswire - Wed Nov 05, 7:00AM CST
At a meeting with analysts and investors at its Investor Day here today, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, plan to discuss the company's industry leadership position and the progress made in executing its strategy to drive shareholder value. A live webcast of the meeting will be broadcast simultaneously beginning at 9 am ET.
DGX: 62.81 (+1.12)
NYSE stocks posting largest volume increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
RCAP: 10.94 (-0.38), LVLT: 46.00 (+0.15), BRP: 23.35 (+0.06), DGX: 62.81 (+1.12), JBL: 21.24 (+0.11), UBA: 22.04 (+0.16), DOV: 81.30 (-0.23), AP: 19.30 (-0.08), UBP: 18.41 (unch), KAMN: 41.40 (+0.15), CVD: 100.66 (+0.14)
After Yesterday's Decline of 1.21%, Quest Diagnostics Offers Investors Better Value
Comtex SmarTrend(R) - Tue Nov 04, 4:03PM CST
Quest Diagnostics (NYSE GX) traded in a range yesterday that spanned from a low of $59.25 to a high of $61.72. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $61.61 on volume of 7.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DGX: 62.81 (+1.12)
Quest Diagnostics Introduces BRCAvantage Plus(TM), Providing New Choices in Genetic Breast Cancer Risk Testing
PR Newswire - Tue Nov 04, 11:50AM CST
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced BRCAvantage Plus, the company's first suite of lab-developed test services for assessing genetic breast cancer risk based on clinically validated non-BRCA as well as BRCA genes. The new service is now available in all 50 states.
DGX: 62.81 (+1.12)
Watch for Shares of Quest Diagnostics (DGX) to Approach Support at $60.50
Comtex SmarTrend(R) - Tue Nov 04, 9:37AM CST
Shares of Quest Diagnostics (NYSE GX) opened today below their pivot of $62.41 and have already reached the first level of support at $61.31. Should the shares continue to fall, the support pivots of $60.50 and $58.59 will be of interest.
DGX: 62.81 (+1.12)
5 Hated Short-Squeeze Stocks That You Should Love
at The Street - Tue Nov 04, 5:00AM CST
These heavily shorted stocks could get squeezed much higher on any positive catalyst.
EXC: 37.53 (-0.24), DGX: 62.81 (+1.12), MTB: 124.06 (-0.48), O: 47.16 (+0.29), ADT: 36.57 (+0.37)
LabCorp Diversifies With $6.1 billion Covance Buyout
at Investor's Business Daily - Mon Nov 03, 11:08AM CST
Diagnostics giant Laboratory Corp. of America (LH) agreed to a $6.1 billion cash-and-stock deal to acquire contract research organization Covance (CVD), or about 105.12 per Covance share, 32% above its closing price Friday. The news sent Covance...
DGX: 62.81 (+1.12), LH: 100.89 (+0.37), CVD: 100.66 (+0.14)
Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 68.86 (+0.89), ESRX: 77.97 (+0.10), DVA: 74.66 (+0.17), DGX: 62.81 (+1.12), MD: 62.24 (+0.06)
LabCorp Outshines Earnings, Revenues in Q3; Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:30PM CDT
Laboratory Corporation of America Holdings (LH) reported third-quarter 2014 adjusted earnings per share (EPS) of $1.80.
CAH: 78.92 (+0.65), DGX: 62.81 (+1.12), LH: 100.89 (+0.37), HSIC: 129.86 (+1.02)
Comparing America's 3 Largest Medical Laboratories And Research Companies
Joseph Cafariello - at Seeking Alpha - Tue Oct 28, 7:27AM CDT
TMO: 116.89 (+0.29), A: 41.32 (+0.39), DGX: 62.81 (+1.12)
6 Fairly Valued Companies Worthy Of Further Research This Week
Benjamin Clark - at Seeking Alpha - Mon Oct 27, 4:33PM CDT
ROP: 158.03 (-0.23), DGX: 62.81 (+1.12), MOS: 44.09 (+0.06), LLY: 68.35 (+1.75), JNPR: 21.44 (-0.47), HUM: 132.63 (+2.05)
Quest Diagnostics' (DGX) CEO Stephen Rusckowski on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 5:45PM CDT
DGX: 62.81 (+1.12)
Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 62.81 (+1.12), AMED: 25.01 (+0.22), HLS: 39.07 (-0.06), GTIV: 19.64 (+0.08)
Quest Diagnostics Incorporated (DGX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 7:25AM CDT
DGX: 62.81 (+1.12)
Quest operating income off 63%
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:37AM CDT
DGX: 62.81 (+1.12)
Quest Diagnostics beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:20AM CDT
DGX: 62.81 (+1.12)
Recent News posted below.
DGX Quest Diagnostics Inc Recent Headline News
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Quest Diagnostics Is Down 1.9% (DGX)
Comtex SmarTrend(R) - 2 hrs 15 mins ago
When Quest Diagnostics (NYSE
GX) reported earnings 18 days ago on October 23rd, 2014, analysts, on average, expected the company to report earnings of $1.07 on sales of $1.9 billion. The company actually reported EPS of $1.10 on sales of $1.9 billion, beating EPS estimates by $0.03 and beating revenue estimates by $32.2 million. Since the company's report, shares of Quest Diagnostics have fallen from $62.88 to $61.69, representing a loss of 1.9% in the past 18 days. DGX: 62.81 (+1.12)
Technical Updates, Quarterly Earnings, Legislated Requirements, Lawsuit Dismissal, and Revised Operational Structure - Research Reports on United Rentals, Lilly, Quest Diagnostics, Agilent and GE
PR Newswire - Thu Nov 06, 7:40AM CST
Today, Analysts Review released its research reports regarding United Rentals, Inc. (NYSE: URI), Eli Lilly and Company (NYSE: LLY), Quest Diagnostics Inc. (NYSE: DGX), Agilent Technologies Inc. (NYSE: A) and General Electric Company (NYSE: GE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7739-100free.
GE: 26.44 (+0.03), A: 41.32 (+0.39), DGX: 62.81 (+1.12), LLY: 68.35 (+1.75), URI: 113.66 (+0.27)
Quest Diagnostics (DGX): Stock With Unusual Social Activity
at The Street - Wed Nov 05, 9:35AM CST
Trade-Ideas LLC identified Quest Diagnostics (DGX) as an unusual social activity candidate
DGX: 62.81 (+1.12)
Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents Outlook at Investor Day
PR Newswire - Wed Nov 05, 7:00AM CST
At a meeting with analysts and investors at its Investor Day here today, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, plan to discuss the company's industry leadership position and the progress made in executing its strategy to drive shareholder value. A live webcast of the meeting will be broadcast simultaneously beginning at 9 am ET.
DGX: 62.81 (+1.12)
NYSE stocks posting largest volume increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
RCAP: 10.94 (-0.38), LVLT: 46.00 (+0.15), BRP: 23.35 (+0.06), DGX: 62.81 (+1.12), JBL: 21.24 (+0.11), UBA: 22.04 (+0.16), DOV: 81.30 (-0.23), AP: 19.30 (-0.08), UBP: 18.41 (unch), KAMN: 41.40 (+0.15), CVD: 100.66 (+0.14)
After Yesterday's Decline of 1.21%, Quest Diagnostics Offers Investors Better Value
Comtex SmarTrend(R) - Tue Nov 04, 4:03PM CST
Quest Diagnostics (NYSE
GX) traded in a range yesterday that spanned from a low of $59.25 to a high of $61.72. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $61.61 on volume of 7.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DGX: 62.81 (+1.12)
Quest Diagnostics Introduces BRCAvantage Plus(TM), Providing New Choices in Genetic Breast Cancer Risk Testing
PR Newswire - Tue Nov 04, 11:50AM CST
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced BRCAvantage Plus, the company's first suite of lab-developed test services for assessing genetic breast cancer risk based on clinically validated non-BRCA as well as BRCA genes. The new service is now available in all 50 states.
DGX: 62.81 (+1.12)
Watch for Shares of Quest Diagnostics (DGX) to Approach Support at $60.50
Comtex SmarTrend(R) - Tue Nov 04, 9:37AM CST
Shares of Quest Diagnostics (NYSE
GX) opened today below their pivot of $62.41 and have already reached the first level of support at $61.31. Should the shares continue to fall, the support pivots of $60.50 and $58.59 will be of interest. DGX: 62.81 (+1.12)
5 Hated Short-Squeeze Stocks That You Should Love
at The Street - Tue Nov 04, 5:00AM CST
These heavily shorted stocks could get squeezed much higher on any positive catalyst.
EXC: 37.53 (-0.24), DGX: 62.81 (+1.12), MTB: 124.06 (-0.48), O: 47.16 (+0.29), ADT: 36.57 (+0.37)
LabCorp Diversifies With $6.1 billion Covance Buyout
at Investor's Business Daily - Mon Nov 03, 11:08AM CST
Diagnostics giant Laboratory Corp. of America (LH) agreed to a $6.1 billion cash-and-stock deal to acquire contract research organization Covance (CVD), or about 105.12 per Covance share, 32% above its closing price Friday. The news sent Covance...
DGX: 62.81 (+1.12), LH: 100.89 (+0.37), CVD: 100.66 (+0.14)
Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 68.86 (+0.89), ESRX: 77.97 (+0.10), DVA: 74.66 (+0.17), DGX: 62.81 (+1.12), MD: 62.24 (+0.06)
LabCorp Outshines Earnings, Revenues in Q3; Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:30PM CDT
Laboratory Corporation of America Holdings (LH) reported third-quarter 2014 adjusted earnings per share (EPS) of $1.80.
CAH: 78.92 (+0.65), DGX: 62.81 (+1.12), LH: 100.89 (+0.37), HSIC: 129.86 (+1.02)
Comparing America's 3 Largest Medical Laboratories And Research Companies
Joseph Cafariello - at Seeking Alpha - Tue Oct 28, 7:27AM CDT
TMO: 116.89 (+0.29), A: 41.32 (+0.39), DGX: 62.81 (+1.12)
6 Fairly Valued Companies Worthy Of Further Research This Week
Benjamin Clark - at Seeking Alpha - Mon Oct 27, 4:33PM CDT
ROP: 158.03 (-0.23), DGX: 62.81 (+1.12), MOS: 44.09 (+0.06), LLY: 68.35 (+1.75), JNPR: 21.44 (-0.47), HUM: 132.63 (+2.05)
Quest Diagnostics' (DGX) CEO Stephen Rusckowski on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 5:45PM CDT
DGX: 62.81 (+1.12)
Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 62.81 (+1.12), AMED: 25.01 (+0.22), HLS: 39.07 (-0.06), GTIV: 19.64 (+0.08)
Quest Diagnostics Incorporated (DGX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 7:25AM CDT
DGX: 62.81 (+1.12)
Quest operating income off 63%
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:37AM CDT
DGX: 62.81 (+1.12)
Quest Diagnostics beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:20AM CDT
DGX: 62.81 (+1.12)
